NEXTNRG, Inc. Faces Nasdaq Delisting, Appeals After 1-for-10 Reverse Split

What Happened NEXTNRG, Inc. (NXXT) disclosed that Nasdaq notified the company it no longer met the $1.00 minimum bid price requirement after a 30‑business‑day deficiency and gave a 180‑day cure period ending September 14, 2026. Because the company had not regained compliance as of September 15, 2026, Nasdaq issued a delisting determination. NEXTNRG has paid the hearing fee and intends to timely request a hearing before the Nasdaq Hearings Panel, which will stay any delisting action while the appeal is pending. The company also completed a one‑for‑ten (1‑for‑10) reverse stock split effective 12:01 a.m. on September 14, 2026; since the reverse split the stock has traded above $1.00.

Key Details

• Nasdaq minimum bid requirement: $1.00 per share (Listing Rule 5550(a)(2)); deficiency existed for 30 consecutive business days.
• Initial notice received: March 16, 2026; 180‑day cure deadline: September 14, 2026.
• Delisting notice issued: September 15, 2026; deadline to request hearing: September 22, 2026.
• Corporate action: 1‑for‑10 reverse split effective September 14, 2026; company paid hearing fee and intends to appeal.
• Nasdaq stated the company is not eligible for a second 180‑day compliance period due to insufficient stockholders’ equity.

Why It Matters A Nasdaq delisting would reduce liquidity and could make the stock harder to buy, sell or include on major broker platforms — materially affecting retail investors. The company’s timely hearing request pauses delisting while the Panel reviews the case, but there is no guarantee the appeal will succeed. The recent 1‑for‑10 reverse split temporarily raised the per‑share price above $1.00, but the filing warns there is no assurance the price will remain above the minimum bid requirement. Retail investors should monitor the Panel outcome and the company’s future filings for updates.